The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis

被引:0
作者
Sherief R. Janmohamed
Eran C. Gwillim
Muhammad Yousaf
Kevin R. Patel
Jonathan I. Silverberg
机构
[1] Universitair Ziekenhuis Brussel (UZB),Department of Dermatology
[2] Vrije Universiteit Brussel (VUB),Department of Dermatology
[3] Northwestern University,Department of Dermatology
[4] Feinberg School of Medicine,undefined
[5] Massachusetts General Hospital,undefined
[6] Harvard Medical School,undefined
[7] George Washington University School of Medicine,undefined
来源
Archives of Dermatological Research | 2021年 / 313卷
关键词
Besnier; Chronic itch; DLQI; EQ5D; Hyde’s prurigo; Itch; IchyQoL; Meta-analysis; Nodular prurigo; NRS; Prurigo; Prurigo nodularis; Pruritis; Pruritus; QoL; Quality of life; Systematic review; VAS; VRS;
D O I
暂无
中图分类号
学科分类号
摘要
Prurigo nodularis (PN) is a chronic, pruritic, debilitating disease. Previous studies found that chronic pruritus in general negatively affects patients’ quality of life (QoL). However, results about the impact of PN on QoL are conflicting. Our objective was to assess the QoL burden of PN. A systematic review was conducted of all published studies that assessed QoL measures in PN. OVID MEDLINE, EMBASE, SCOPUS, and Web of Science were searched. Pooled meta-analysis (means) was performed using random-effects weighting. Overall, 13 studies met inclusion criteria. All studies identified QoL reductions in patients suffering from PN compared to control groups. The most common QoL instrument used was the Dermatology Life Quality Index [n = 9 studies; pooled mean (95% confidence interval): 13.8 (10.6–16.9), denoting a very large effect]. In particular, PN was associated with substantial impact on multiple domains of QoL. No publication bias was detected. In conclusion, QoL is negatively impacted in PN. Future studies are necessary to determine the best instruments of measuring QoL in PN patients, better understand this association, and assess the impact in males and females separately. PROSPERO CRD42019136193.
引用
收藏
页码:669 / 677
页数:8
相关论文
共 151 条
[1]  
Zeidler C(2018)Chronic prurigo of nodular type: a review ActaDermatoVenereol 98 173-179
[2]  
Tsianakas A(2007)Clinical classification of itch: a position paper of the International Forum for the Study of Itch ActaDermatoVenereol 87 291-294
[3]  
Pereira M(2018)European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo J EurAcadDermatolVenereol : JEADV 32 1059-1065
[4]  
Stander H(2020)Diagnostic and treatment algorithm for chronic nodular prurigo J Am AcadDermatol 82 460-468
[5]  
Yosipovitch G(2012)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163-2196
[6]  
Stander S(2016)Itch in the general internal medicine setting: a cross-sectional study of prevalence and quality-of-life effects Am J ClinDermatol 17 681-690
[7]  
Stander S(2018)Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study Annal Allergy Asthma Immunol 121 340-347
[8]  
Weisshaar E(2009)Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation Allergy 64 581-588
[9]  
Mettang T(2016)A review of the efficacy of thalidomide and lenalidomide in the treatment of refractory prurigonodularis DermatolTher 6 397-411
[10]  
Pereira MP(2018)The impact of oral food challenges for food allergy on quality of life: a systematic review Pediatr Allergy Immunol 29 527-537